PWS
ABBV icon

Paragon Wealth Strategies’s AbbVie ABBV Stock Holding History

Paragon Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-332
Closed -$53.6K – 37
2022
Q4 		$53.6K Sell
332
-50
-13% -$7.67K 0.06% 61
2022
Q3 		$51K Buy
+382
New +$54.8K 0.05% 42
2021
Q3 		– Sell
-64
Closed -$7K – 43
2021
Q2 		$7K Buy
+64
New +$7.21K ﹤0.01% 207

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Paragon Wealth Strategies's ABBV Position: Q1 2023 in Review

Paragon Wealth Strategies sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 332 shares — an estimated $53.6K sold.

Paragon Wealth Strategies first reported a position in ABBV in Q2 2021 and held it in 3 quarters. The position peaked at $53.6K in Q4 2022. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Paragon Wealth Strategies reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • Paragon Wealth Strategies sold 332 AbbVie shares in Q1 2023, an estimated $53.6K.
  • Paragon Wealth Strategies first reported a position in AbbVie in Q2 2021 and held it in 3 quarters.
  • Paragon Wealth Strategies's AbbVie position peaked at $53.6K in Q4 2022.
  • 3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Paragon Wealth Strategies's 13F filing for Q1 2023, filed 26 Apr 2023.